Self monitoring v management by healthcare professionals (control) in patients receiving oral anticoagulant therapy*
| Outcomes at 2–24 months | Self monitoring category | Number of studies (n) | Weighted event rates | RRR (95% CI) | NNT (CI) | |
|---|---|---|---|---|---|---|
| Self monitoring | Control | |||||
| *Abbreviations defined in glossary; weighted event rates, RRR, NNT, and CI calculated from data in article using a fixed effects model. | ||||||
| Thromboembolic event | Self test | 6 (1341) | 3.8% | 6.5% | 41% (6.6 to 64) | 38 (25 to 234) |
| Self manage | 8 (1629) | 0.8% | 3.0% | 72% (40 to 88) | 46 (38 to 82) | |
| Both | 14 (2970) | 2.1% | 4.6% | 54% (31 to 69) | 41 (32 to 71) | |
| Major bleeding | Self test | 5 (1191) | 4.0% | 7.0% | 42% (6.5 to 64) | 34 (23 to 219) |
| Self manage | 8 (1629) | 1.3% | 1.4% | 6.9% (−102 to 58) | Not significant | |
| Both | 13 (2820) | 2.5% | 3.7% | 34% (1.0 to 57) | 79 (47 to 2778) | |
| Death | Self test | 4 (1028) | 4.2% | 5.1% | 18% (−45 to 55) | Not significant |
| Self manage | 6 (1374) | 1.1% | 3.0% | 62% (15 to 84) | 54 (40 to 227) | |
| Both | 10 (2402) | 2.4% | 3.9% | 38% (1.9 to 61) | 68 (42 to 1329) | |